CD8


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
12 2021
Historique:
received: 28 03 2021
accepted: 17 09 2021
pubmed: 26 9 2021
medline: 4 1 2022
entrez: 25 9 2021
Statut: ppublish

Résumé

In type 1 diabetes, autoimmune β-cell destruction may be favored by neoantigens harboring posttranslational modifications (PTMs) such as citrullination. We studied the recognition of native and citrullinated glucose-regulated protein (GRP)78 peptides by CD8

Identifiants

pubmed: 34561224
pii: db21-0259
doi: 10.2337/db21-0259
pmc: PMC8660990
doi:

Substances chimiques

Endoplasmic Reticulum Chaperone BiP 0
Epitopes, T-Lymphocyte 0

Banques de données

figshare
['10.2337/figshare.16654669']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2879-2891

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK116073
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK032083
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099317
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK127786
Pays : United States

Informations de copyright

© 2021 by the American Diabetes Association.

Références

Cell Chem Biol. 2018 Jun 21;25(6):691-704.e6
pubmed: 29628436
JCI Insight. 2018 Dec 20;3(24):
pubmed: 30568038
Nat Med. 2016 Dec;22(12):1482-1487
pubmed: 27798614
J Immunol Res. 2019 Nov 25;2019:7592851
pubmed: 31886309
Diabetes. 2018 Nov;67(11):2337-2348
pubmed: 30348823
J Exp Med. 2016 Sep 19;213(10):2129-46
pubmed: 27621416
Sci Adv. 2020 Oct 16;6(42):
pubmed: 33067232
Diabetes. 2015 Feb;64(2):573-86
pubmed: 25204978
Immunity. 2015 Nov 17;43(5):833-5
pubmed: 26588773
Diabetes. 2021 Feb;70(2):516-528
pubmed: 33203696
Clin Exp Immunol. 2020 Mar;199(3):263-277
pubmed: 31660582
Diabetes. 2015 Mar;64(3):916-925
pubmed: 25249579
Elife. 2020 Apr 29;9:
pubmed: 32338592
Gene. 2017 Jun 30;618:14-23
pubmed: 28286085
J Proteome Res. 2021 Feb 5;20(2):1405-1414
pubmed: 33372785
Nat Immunol. 2020 Apr;21(4):455-463
pubmed: 32152506
Transplantation. 1998 May 15;65(9):1225-32
pubmed: 9603172
Cell. 2017 Oct 19;171(3):655-667.e17
pubmed: 29053971
Diabetes. 2020 Dec;69(12):2678-2690
pubmed: 32928873
PLoS One. 2016 Jun 30;11(6):e0158773
pubmed: 27362943
Nat Biotechnol. 2003 Jan;21(1):57-63
pubmed: 12496764
Diabetologia. 2021 Jan;64(1):15-25
pubmed: 33084970
Nat Commun. 2018 Jan 24;9(1):353
pubmed: 29367624
Diabetologia. 2020 Oct;63(10):1999-2006
pubmed: 32894310
Front Immunol. 2018 Sep 19;9:2120
pubmed: 30283453
Nat Rev Immunol. 2018 Feb;18(2):134-147
pubmed: 28990587
Arthritis Rheum. 2010 May;62(5):1213-23
pubmed: 20213805
J Clin Invest. 2020 Jan 2;130(1):480-490
pubmed: 31815738
Immunity. 2015 May 19;42(5):929-41
pubmed: 25992863
Cell Death Dis. 2019 Apr 5;10(4):309
pubmed: 30952835
Diabetologia. 2017 Mar;60(3):475-489
pubmed: 28078386
PLoS One. 2008 Feb 27;3(2):e1678
pubmed: 18301755
Cell Metab. 2018 Dec 4;28(6):946-960.e6
pubmed: 30078552
Sci Immunol. 2018 Feb 2;3(20):
pubmed: 29429978
Diabetes. 2018 Jun;67(6):1035-1042
pubmed: 29784651
Blood. 2010 May 6;115(18):3718-25
pubmed: 20200354
J Biol Chem. 2019 Feb 8;294(6):2109-2120
pubmed: 30401745

Auteurs

Marie Eliane Azoury (ME)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France.

Fatoumata Samassa (F)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France.

Mijke Buitinga (M)

Laboratory of Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.

Laura Nigi (L)

Toscana Life Sciences, Diabetes Unit and Fondazione Umberto di Mario ONLUS, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Noemi Brusco (N)

Toscana Life Sciences, Diabetes Unit and Fondazione Umberto di Mario ONLUS, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Aïsha Callebaut (A)

Laboratory of Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.

Matthieu Giraud (M)

Centre de Recherche en Transplantation et Immunologie, INSERM UMR1064, Université de Nantes, Nantes, France.

Magali Irla (M)

Centre d'Immunologie de Marseille-Luminy, INSERM, CNRS, Aix-Marseille University, Marseille, France.

Ana Ines Lalanne (AI)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France.

Alexia Carré (A)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France.

Georgia Afonso (G)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France.

Zhicheng Zhou (Z)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France.

Barbara Brandao (B)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France.

Maikel L Colli (ML)

Medical Faculty, Center for Diabetes Research and Welbio, Université Libre de Bruxelles, Brussels, Belgium.

Guido Sebastiani (G)

Toscana Life Sciences, Diabetes Unit and Fondazione Umberto di Mario ONLUS, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Francesco Dotta (F)

Toscana Life Sciences, Diabetes Unit and Fondazione Umberto di Mario ONLUS, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Maki Nakayama (M)

Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO.

Decio L Eizirik (DL)

Medical Faculty, Center for Diabetes Research and Welbio, Université Libre de Bruxelles, Brussels, Belgium.
Indiana Biosciences Research Institute, Indianapolis, IN.

Sylvaine You (S)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France.

Sheena Pinto (S)

Division of Developmental Immunology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.

Mark J Mamula (MJ)

Yale University School of Medicine, New Haven, CT.

Yann Verdier (Y)

ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UMR8249, Paris, France.

Joelle Vinh (J)

ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UMR8249, Paris, France.

Soren Buus (S)

Department of International Health, Immunology and Microbiology, Panum Institute, Copenhagen, Denmark.

Chantal Mathieu (C)

Laboratory of Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.

Lut Overbergh (L)

Laboratory of Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.

Roberto Mallone (R)

Université de Paris, Institut Cochin, CNRS, INSERM, Paris, France roberto.mallone@inserm.fr.
Assistance Publique Hôpitaux de Paris, Service de Diabétologie et Immunologie Clinique, Cochin Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH